4-Chloro-α-pyrrolidinovalerophenone (also known as 4-chloro-α-pyrrolidinopentiophenone, 4-chloro-α-PVP, 4Cl-PVP, or 4C-PVP, or alpha-PVP, or flakka) is an emerging recreational designer drug of the pyrrolidinophenone class, similar in structure to α-pyrrolidinopentiophenone (α-PVP).[1] The pharmacology and toxicity of this compound is unknown, though it is presumed to be a stimulant drug.
 | |
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, intranasal, intravenous, rectal, |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H20ClNO |
| Molar mass | 265.78 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In the United States, 4-chloro-α-PVP is a Schedule I Controlled Substance.[2]
See also
editReferences
edit- ^ Lopes BT, Caldeira MJ, Gaspar H, Antunes AM (2020). "Metabolic Profile of Four Selected Cathinones in Microsome Incubations: Identification of Phase I and II Metabolites by Liquid Chromatography High Resolution Mass Spectrometry". Frontiers in Chemistry. 8: 609251. doi:10.3389/fchem.2020.609251. PMC 7835677. PMID 33511100.
- ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-29.